Glifor 1000 mg Billim Ilac

Description

Glifor 1000 mg Billim Ilac — metformin from Billim Ilac at 1000 mg. Biguanide reducing hepatic glucose production and improving insulin sensitivity. First-line type-2 diabetes therapy; off-label glucose management during HGH cycles.

Key Benefits

• First-line T2DM medication — biguanide class
• Glucose control via hepatic gluconeogenesis suppression
• Modest weight-loss effect in non-diabetic users
• Insulin-sensitisation — useful on HGH/GH-axis compound cycles
• Oral dosing, start low to minimise GI side-effects
• Each unit dosed at 1000 mg — see Recommended Dosage below for protocol-specific intake

How It Works

Activates AMPK in hepatocytes, suppressing gluconeogenesis. Reduces fasting glucose, HbA1c, and improves insulin sensitivity. Modest weight-loss effect in insulin-resistant individuals. Not directly a fat-burner.

Pharmacokinetics

Plasma half-life approximately 6 hours. Twice-daily immediate-release or once-daily extended-release. Not metabolised — renally excreted. Monitor kidney function in long-term users.

Potential Side Effects

GI upset (nausea, diarrhoea, bloating) common during titration — resolves at stable dose. Vitamin B12 depletion on long runs — supplement. Rare lactic-acidosis risk in kidney-impaired users.

Cycle & Stacking Guide

Long-term T2DM treatment. For performance users: insulin-sensitisation during HGH cycles at 500–1000 mg/day. Bloodwork every 3 months.

Manufacturer Notes

Billim Ilac is a Turkish generic pharmaceutical producer. Their metformin and related products are dispensed through European pharmacy channels.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.